Neuroscientific Biopharmaceuticals Ltd (nsb) Logo

Neuroscientific Biopharmaceuticals Ltd (NSB)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

NSB ASX Chart

Snapshot

NeuroScientific Biopharmaceuticals Ltd (NSB) is a biotechnology company focused on the development of novel therapeutics targeting immune-mediated inflammatory disorders. The Company's research is centred on modulating pathological immune responses involved in chronic and degenerative conditions, where current therapeutic options demonstrate limited efficacy or durability. NSB applies advanced preclinical and translational strategies to support the development of biologics addressing unmet clinical need

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -13.70%
vs ASX 200 (1yr) -52.52%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,558 of 2,337
Sector Rank 136 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies MDC / 1AI / NTI
EPS -$0.015
DPS $0.00
Book Value Per Share $0.042

Broker Consensus

NSB is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Perth WA 6000
Website www.neuroscientific.com
Registry Automic Group
Auditor Nexia Perth Audit Services Pty Ltd
Date Listed 27 Jul 2018

Upcoming Calendar (Forecasted)

Date Event
27/08/2026 Report (Prelim)
27/08/2026 Report (Annual)
24/02/2027 Report (Interim)

Former Company Names

  • Neuroscientific Biopharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

NSB directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
01/06/26 Paul Fry Buy +8,988,641 $0.09 $808,977 Conversion of securities
01/06/26 Paul Fry Exercise 8,988,641 $0.09 $808,977 Conversion of securities
01/06/26 Robert McKenzie Buy +3,854,317 $0.09 $346,888 Conversion of securities
01/06/26 Robert McKenzie Exercise 3,854,317 $0.09 $346,888 Conversion of securities
27/06/25 Anton Uvarov Issued 2,650,000 $0.035 $92,750 Placement
27/06/25 Clarke Barlow Issued 1,000,000 $0.00 $100 As advised by the company
27/06/25 Anton Uvarov Issued 1,000,000 $0.00 $100 As advised by the company
04/07/23 Stephen Quantrill Buy +180,000 $0.097 $17,375 On-market trade
01/06/23 Paul Rennie Buy +240,134 $0.10 $23,989 On-market trade
24/05/23 Paul Rennie Buy +229,651 $0.097 $22,378 On-market trade
22/05/23 Anton Uvarov Buy +49,405 $0.105 $5,188 On-market trade
18/05/23 Anton Uvarov Buy +275,595 $0.084 $23,188 On-market trade
17/05/23 Paul Rennie Buy +320,968 $0.083 $26,710 On-market trade
07/12/21 Stephen Quantrill Issued 600,000 $0.32 $192,000 Director remuneration
07/12/21 Anton Uvarov Issued 900,000 $0.32 $288,000 Director remuneration
07/12/21 Paul Rennie Issued 5,600,000 $0.32 $1,792,000 Director remuneration
07/12/21 Matthew Liddelow Issued 900,000 $0.32 $288,000 Director remuneration
09/07/21 Paul Rennie Buy +300,000 $0.332 $99,672 On-market trade
18/05/21 Matthew Liddelow Buy +50,000 $0.243 $12,154 On-market trade
13/05/21 Brian Leedman Buy +123,447 $0.225 $27,806 On-market trade
13/05/21 Stephen Quantrill Buy +30,000 $0.226 $6,769 On-market trade
01/03/21 Brian Leedman Sell +100,000 $0.004 ($370) On-market trade
25/02/21 Anton Uvarov Sell +250,000 $0.015 ($3,647) On-market trade
25/02/21 Anton Uvarov Exercise 400,000 $0.20 $80,000 Exercise of options
25/02/21 Anton Uvarov Exercise 400,000 $0.20 $80,000 Exercise of options
25/02/21 Anton Uvarov Buy +400,000 $0.20 $80,000 Exercise of options
18/02/21 Brian Leedman Sell +300,000 $0.248 ($74,498) On-market trade
18/02/21 Brian Leedman Buy +600,000 $0.20 $120,000 Exercise of options
18/02/21 Brian Leedman Exercise 600,000 $0.20 $120,000 Exercise of options
15/01/21 Anton Uvarov Issued 800,000 $0.25 $200,000 Director remuneration
15/01/21 Stephen Quantrill Issued 500,000 $0.25 $125,000 Director remuneration
15/01/21 Matthew Liddelow Issued 1,200,000 $0.25 $300,000 Director remuneration
27/07/20 Brian Leedman Issued 700,000 $0.195 $136,500 Director remuneration
06/12/18 Anton Uvarov Issued 650,000 $0.01 $6,500 Rights issue
06/12/18 Brian Leedman Issued 700,000 $0.01 $7,000 Rights issue
22/11/18 Brian Leedman Buy +91,875 $0.19 $17,417 On-market trade
22/11/18 Brian Leedman Buy +88,130 $0.16 $14,132 On-market trade
Show All

Director Interests

The current holdings of NSB directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Robert McKenzie 01/06/2026 N/A 9,635,792 5,000,000 N/A
Paul Fry 01/06/2026 N/A 22,471,602 5,000,000 N/A
Clarke Barlow 30/06/2025 N/A N/A 1,000,000 N/A
Anton Uvarov 30/06/2025 3,000,000 2,000,000 1,000,000 N/A
Linda Friedland N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 25, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
BNP Paribas Noms Pty Ltd 26,625,425 10.79%
Mcrae Technology Pty Ltd 19,122,262 7.75%
Citicorp Nominees Pty Limited 12,944,993 5.24%
The Trust Company (Australia) Limited <Sbf A/C> 5,561,704 2.25%
Goldfire Enterprises Pty Ltd 4,544,286 1.84%
Utas Holdings Pty Ltd 3,954,123 1.60%
Mr Anton Uvarov 3,000,000 1.22%
Ratdog Pty Ltd 2,857,143 1.16%
Ecu Holdings Pty Ltd 2,555,556 1.04%
J P Morgan Nominees Australia Pty Limited 2,475,000 1.00%
Solequest Pty Ltd 2,411,206 0.98%
Trevor Burrows Investment Pty Ltd <Trevor Burrows Inv S/F A/C> 2,300,000 0.93%
Ice Lake Investments Pty Ltd 2,250,000 0.91%
Hsbc Custody Nominees (Australia) Limited 2,208,912 0.89%
Charlton Wa Pty Ltd <Tinamara Super Fund A/C> 2,150,000 0.87%
Tt Nicholls Pty Ltd <Nicholls Super Fund A/C> 2,150,000 0.87%
Mr Edward Joseph Gettingby & Mrs Margaret Mary Gettingby 2,090,000 0.85%
Ms Yulia Uvarova <Techinvest Nominees A/C> 2,000,000 0.81%
Platinum Reign Pty Ltd 2,000,000 0.81%
Massif Holdings Pty Ltd 1,950,000 0.79%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 53 381 281 648 277 1,640

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Mr Paul Damien John Fry 01/06/2026 22,471,602 5.77
Stum West Pty Ltd 01/06/2026 41,320,713 10.60

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
01-06-26 Stum West Pty Ltd 16,528,285 7.45 10.60
01-06-26 Mr Paul Damien John Fry 22,471,602 -- 5.77

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
17-09-25 McRae Technology Pty Ltd 18,543,954 25.20 --
28-07-25 McRae Investments Pty Ltd 4,985,659 7.25 5.75

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.087 30 June
2024 $0.04 28 June
2023 $0.08 30 June
2022 $0.18 30 June
2021 $0.335 30 June
2020 $0.19 30 June
2019 $0.145 28 June
NSB Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.